ºÝºÝߣ

ºÝºÝߣShare a Scribd company logo

Documents(17)Ìý

See all
Targetting cancer with Ru(III/II)-phosphodiesterase inhibitor adducts: A novel approach in the treatment of cancer
Targetting cancer with Ru(III/II)-phosphodiesterase inhibitor adducts: A novel approach in the treatment of cancerTargetting cancer with Ru(III/II)-phosphodiesterase inhibitor adducts: A novel approach in the treatment of cancer
Targetting cancer with Ru(III/II)-phosphodiesterase inhibitor adducts: A novel approach in the treatment of cancer
Ìý
An overview of the toxic effect of potential human carcinogen Microcystin-LR on testis
An overview of the toxic effect of potential human carcinogen Microcystin-LR on testisAn overview of the toxic effect of potential human carcinogen Microcystin-LR on testis
An overview of the toxic effect of potential human carcinogen Microcystin-LR on testis
Ìý
Activation of p53 mediated glycolytic inhibition-oxidative stressapoptosis pathway in Dalton's lymphoma by a ruthenium (II)-complex containing 4-carboxy N-ethylbenzamide
Activation of p53 mediated glycolytic inhibition-oxidative stressapoptosis pathway in Dalton's lymphoma by a ruthenium (II)-complex containing 4-carboxy N-ethylbenzamideActivation of p53 mediated glycolytic inhibition-oxidative stressapoptosis pathway in Dalton's lymphoma by a ruthenium (II)-complex containing 4-carboxy N-ethylbenzamide
Activation of p53 mediated glycolytic inhibition-oxidative stressapoptosis pathway in Dalton's lymphoma by a ruthenium (II)-complex containing 4-carboxy N-ethylbenzamide
Ìý